drugset / Trial / NCT07217067
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized, placebo-controlled, participant-and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden as well as the safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation
Timeline
- Start
- 2025-10-28
- Primary completion
- 2027-09-09
- Completion
- 2027-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PKN605 | Unknown | — | Oral |